Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Early customers describe founders personally answering questions and resolving issues same-day
Future Research on GLP-1RA Use in T1D Consequently, the researchers called for large-scale randomized controlled trials to confirm these results and determine which specific GLP-1RA or dosage works best for the T1D population
Therefore, both temporal and spatial considerations of IGF-1R modulation will need to be considered in future trials with these drugs in order to clearly define the benefits and potential risks associated with this treatment, and guide development of strategies that allow for safe and effective long-term human use
Semaglutide in early type 1 diabetes
Across the retatrutide trials so far, rates have ranged from 2 to 11% in active groups (depending on dose) versus 2% on placebo
The clinical approach remains sound regardless of whether the specific mechanism is correct
